Jennifer J. Rhodes - Nov 15, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Signature
/s/ Jennifer J. Rhodes
Stock symbol
ELTX
Transactions as of
Nov 15, 2021
Transactions value $
-$1,905
Form type
4
Date filed
11/16/2021, 03:09 PM
Previous filing
Oct 15, 2021
Next filing
Dec 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale -$1.91K -433 -1.38% $4.40 30.9K Nov 15, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted by the Issuer.

Remarks:

Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary